Whitehouse Rebecca L, Alwan Wesam S, Ilyichova Olga V, Taylor Ashley J, Chandrashekaran Indu R, Mohanty Biswaranjan, Doak Bradley C, Scanlon Martin J
Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University Parkville VIC 3052 Australia
Australian Synchrotron, ANSTO Clayton VIC 3168 Australia.
RSC Med Chem. 2022 Nov 29;14(1):135-143. doi: 10.1039/d2md00253a. eCollection 2023 Jan 25.
Fragment-based drug design relies heavily on structural information for the elaboration and optimisation of hits. The ability to identify neighbouring binding hot spots, energetically favourable interactions and conserved binding motifs in protein structures through X-ray crystallography can inform the evolution of fragments into lead-like compounds through structure-based design. The composition of fragment libraries can be designed and curated to fit this purpose and herein, we describe and compare screening libraries containing compounds comprising between 2 and 18 heavy atoms. We evaluate the properties of the compounds in these libraries and assess their ability to probe protein surfaces for binding hot spots.
基于片段的药物设计在很大程度上依赖于用于命中物的阐述和优化的结构信息。通过X射线晶体学识别蛋白质结构中相邻的结合热点、能量上有利的相互作用和保守的结合基序的能力,可以通过基于结构的设计指导片段演变成类先导化合物。片段库的组成可以进行设计和管理以符合这一目的,在此,我们描述并比较了包含由2至18个重原子组成的化合物的筛选库。我们评估了这些库中化合物的性质,并评估了它们探测蛋白质表面结合热点的能力。